ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 128 filers reported holding ANAPTYSBIO INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,713,859 | -8.1% | 206,785 | +4.1% | 0.02% | -4.3% |
| Q2 2023 | $4,041,985 | +16.5% | 198,721 | +24.6% | 0.02% | +9.5% |
| Q1 2023 | $3,470,872 | +1026.9% | 159,507 | +949.7% | 0.02% | +950.0% |
| Q2 2022 | $308,000 | -88.8% | 15,196 | -86.4% | 0.00% | -89.5% |
| Q1 2022 | $2,756,000 | -11.2% | 111,407 | +24.7% | 0.02% | -9.5% |
| Q4 2021 | $3,104,000 | +29.4% | 89,317 | +1.0% | 0.02% | +31.2% |
| Q3 2021 | $2,398,000 | +3.7% | 88,428 | -0.8% | 0.02% | 0.0% |
| Q2 2021 | $2,312,000 | +13.9% | 89,166 | -5.3% | 0.02% | 0.0% |
| Q1 2021 | $2,030,000 | +32.2% | 94,205 | +32.0% | 0.02% | +23.1% |
| Q4 2020 | $1,535,000 | +46.9% | 71,378 | +0.7% | 0.01% | +18.2% |
| Q3 2020 | $1,045,000 | -26.5% | 70,851 | +11.4% | 0.01% | -26.7% |
| Q2 2020 | $1,421,000 | +190.6% | 63,591 | +83.9% | 0.02% | +150.0% |
| Q1 2020 | $489,000 | – | 34,585 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |